Proteostasis Ther (PTI) Stock Price, Quote, News and Overview
NYSE:PTI - New York Stock Exchange, Inc. -
PTI Quote, Performance and Key Statistics
1.11
-0.04 (-3.48%)
The current stock price of PTI is 1.11 null. In the past month the price increased by 8.82%. In the past year, price decreased by -50.22%.
About PTI
Company Profile
Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.
Company Info
Proteostasis Ther
80 Guest Street Suite 500
Boston MA 02135
CEO: Meenu Chhabra
Phone: 617-225-0096
Proteostasis Ther / PTI FAQ
What is the stock price of Proteostasis Ther today?
The current stock price of PTI is 1.11 null. The price decreased by -3.48% in the last trading session.
What is the ticker symbol for Proteostasis Ther stock?
The exchange symbol of Proteostasis Ther is PTI and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PTI stock listed?
PTI stock is listed on the New York Stock Exchange, Inc. exchange.
What is Proteostasis Ther worth?
Proteostasis Ther (PTI) has a market capitalization of 57.93M null. This makes PTI a Micro Cap stock.
What are the support and resistance levels for Proteostasis Ther (PTI) stock?
Proteostasis Ther (PTI) has a support level at 1.02 and a resistance level at 1.2. Check the full technical report for a detailed analysis of PTI support and resistance levels.
Should I buy Proteostasis Ther (PTI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PTI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PTI, evaluating the profitability, health, valuation and growth aspects
- Proteostasis Ther (PTI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Proteostasis Ther (PTI) Sales and EPS estimates to see what analysts future expectations are.
- Proteostasis Ther (PTI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Proteostasis Ther (PTI) Insider and Institutional Ownership to learn about the owners and their transactions.
- Proteostasis Ther (PTI) Stock Chart to make your own analysis
- Proteostasis Ther (PTI) Latest news and press-releases to stay up to date.
Does Proteostasis Ther (PTI) stock pay dividends?
PTI does not pay a dividend.
What is the Price/Earnings (PE) ratio of Proteostasis Ther (PTI)?
Proteostasis Ther (PTI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.75).
PTI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to PTI. When comparing the yearly performance of all stocks, PTI is a bad performer in the overall market: 96% of all stocks are doing better.
PTI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PTI. Both the profitability and financial health of PTI have multiple concerns.
PTI Financial Highlights
Over the last trailing twelve months PTI reported a non-GAAP Earnings per Share(EPS) of -0.75. The EPS increased by 41.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.38% | ||
| ROE | N/A | ||
| Debt/Equity | 0.31 |
PTI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to PTI. The Buy consensus is the average rating of analysts ratings from 2 analysts.